Expression of unusual immunophenotype combinations in acute myelogenous leukemia
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Immunophenotypes for 272 patients with acute myelogenous leukemia (AML) were analyzed using a panel of 22 antibodies. Numerical evidence for unusual coexpressions (present in normal marrow at < or = 0.1%) of surface markers on = or = 10% of the blast cells was found in 85% of all cases. Asynchronous expression of myeloid differentiation antigens occurred in 70% of the cases. Unusual coexpression of T-lymphoid, B- lymphoid, or natural killer (NK) markers with myeloid markers occurred in 38%, 13%, and 21%, respectively, of all AML cases. Two- and three- color analyses confirmed coexpression in 15 of 15 cases, and indicated that these percentages are an underestimate, because coexpression can be demonstrated in cases without numerical overlap. These data indicate that the unusual coexpression of normal differentiation antigens is a common occurrence in AML. Markers in 12 of 13 patients were similar between presentation and relapse, and in two patients, unusual phenotypes detected at first relapse were shown at second relapse, indicating these immunophenotypes are stable in the majority of AML patients. Significant correlations were found between t(8;21) cytogenetics and coexpression of CD19 with CD15 or CD34, t(9;22) and coexpression of CD19 and CD34, and t(15;17) and coexpression of CD2 and myeloid antigens. Multiparameter fluorescence analysis allows detection of unusual phenotypes when the blast counts are < 5% (classical remission). Analysis of 16 patients in remission indicated the presence of presentation phenotypes in 0.2% to 7.9% of the lymphocyte + blast light scatter region, representing 0.03% to 1.4% of the total nucleated marrow cells. Of the 16 patients with = or = 4 months follow-up after detection of these cells, 6 of 6 patients with = or = 0.2% unusual presentation phenotypic marrow cells have relapsed, while 9 of 10 patients with < 0.2% remain in remission. The detection of cells with the unusual presentation phenotype may reflect residual AML cells, and their increase may predict relapse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Bennett, J. M., Catovsky, D., Daniel, M., Flandrin, G., Galton, D. A. G., Gralnick, H. R., & Sultan, C. (1976) · British Journal of Haematology · doi:10.1111/j.1365-2141.1976.tb03563.x · Cited by 5,602
Lineage promiscuity in hemopoietic differentiation and leukemia
Greaves, M., Chan, L., Furley, A., Watt, S., & Molgaard, H. (1986) · Blood · doi:10.1182/blood.v67.1.1.1 · Cited by 551
Kita, K., Nakase, K., Miwa, H., Masuya, M., Nishii, K., Morita, N., Takakura, N., Otsuji, A., Shirakawa, S., & Ueda, T. (1992) · Blood · doi:10.1182/blood.v80.2.470.470 · Cited by 234
Use of surface marker analysis to predict outcome of adult acute myeloblastic leukemia
Griffin, J., Davis, R., Nelson, D., Davey, F., Mayer, R., Schiffer, C., McIntyre, O., & Bloomfield, C. (1986) · Blood · doi:10.1182/blood.v68.6.1232.1232 · Cited by 195
Van den Berghe, H. (1988) · British Journal of Haematology · doi:10.1111/j.1365-2141.1988.tb04242.x · Cited by 164
Claxton, D. F., Reading, C., Nagarajan, L., Tsujimoto, Y., Andersson, B., Estey, E. H., Cork, A., Huh, Y., Trujillo, J. M., & Deisseroth, A. (1992) · Blood · doi:10.1182/blood.v80.3.582.582 · Cited by 98
Self-citationRobertson, M. J., Soiffer, R. J., Freedman, A. S., Rabinowe, S. N., Anderson, K. C., Ervin, T., Murray, C., Dear, K. B. G., Griffin, J. D., & Nadler, L. M. (1992) · Blood · doi:10.1182/blood.v79.9.2229.2229 · Cited by 98
Schwarzinger, I., Valent, P., Köller, U., Marosi, C., Schneider, B., Haas, O., Knapp, W., Lechner, K., & Bettelheim, P. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.3.423 · Cited by 92
Human monomyeloid cell membrane antigens.
Civin, C. I. (1990) · PubMed · Cited by 88
Cited by
Recent Advances in Flow Cytometry: Application to the Diagnosis of Hematologic Malignancy
Jennings, C. D., & Foon, K. A. (1997) · Blood · doi:10.1182/blood.v90.8.2863 · Cited by 447
San Miguel, J. F., Vidriales, M. B., López-Berges, C., Dı́az-Mediavilla, J., Gutiérrez, N., Cañizo, C., Ramos, F., Calmuntia, M. J., Pérez, J. J., González, M., et al. (2001) · Blood · doi:10.1182/blood.v98.6.1746 · Cited by 335
CD19 Antigen in Leukemia and Lymphoma Diagnosis and Immunotherapy
Scheuermann, R. H., & Racila, E. (1995) · Leukemia & Lymphoma · doi:10.3109/10428199509059636 · Cited by 323
Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia
Sperr, W. R., Jordan, J.-H., Baghestanian, M., Kiener, H.-P., Samorapoompichit, P., Semper, H., Hauswirth, A., Schernthaner, G.-H., Chott, A., Natter, S., et al. (2001) · Blood · doi:10.1182/blood.v98.7.2200 · Cited by 149
Metadata
- Authors
- Reading, C., Estey, E., Huh, Y., Claxton, D., Sanchez, G., Terstappen, L., O'Brien, M., Baron, S., & Deisseroth, A.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1993-06-01
- Volume
- 81
- Issue
- 11
- Pages
- 3083-3090
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2288539878
- Cited by
- 184
- References
- 12
- FWCI
- 6.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Expression of unusual immunophenotype combinations in acute myelogenous leukemia. https://app.cochat.ai/papers/10.1182/blood.v81.11.3083.3083
- The paper
- Reading, C., Estey, E., Huh, Y., Claxton, D., Sanchez, G., Terstappen, L., O'Brien, M., Baron, S., & Deisseroth, A. (1993). Expression of unusual immunophenotype combinations in acute myelogenous leukemia. Blood. https://doi.org/10.1182/blood.v81.11.3083.3083
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.